Published in APMIS on September 01, 1994
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
Transmission of rhinovirus colds by self-inoculation. N Engl J Med (1973) 2.80
Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatrics (2001) 2.72
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
Hand-to-hand transmission of rhinovirus colds. Ann Intern Med (1978) 2.46
Attachment and ingestion of gonococci human neutrophils. Infect Immun (1975) 2.43
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med (1966) 2.27
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis (1975) 2.05
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Non-group A streptococci in the pharynx. Pathogens or innocent bystanders? Am J Dis Child (1989) 1.97
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Methods to improve detection of pneumococci in respiratory secretions. J Clin Microbiol (1975) 1.94
Etiology of acute conjunctivitis in children. J Pediatr (1981) 1.92
Alteration of cerebrospinal fluid findings by partial treatment of bacterial meningitis. J Pediatr (1973) 1.77
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis (1974) 1.62
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
Adherence of Bordetella pertussis to human respiratory epithelial cells. J Infect Dis (1983) 1.54
B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections. J Urol (2011) 1.50
Interruption of experimental rhinovirus transmission. J Infect Dis (1980) 1.47
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Kinins are generated during experimental rhinovirus colds. J Infect Dis (1988) 1.44
Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatr (1999) 1.39
Activation and transmission in rats of infection with Pneumocystis. Proc Soc Exp Biol Med (1971) 1.36
Species specificity of Bordetella adherence to human and animal ciliated respiratory epithelial cells. Infect Immun (1983) 1.36
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA (1967) 1.33
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
Improved method for collection of nasal mucus. J Infect Dis (1977) 1.31
Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA (1986) 1.30
A decongestant-antihistamine mixture in the prevention of otitis media in children with colds. Pediatrics (1979) 1.29
The emergence of Haemophilus influenzae types e and f as significant pathogens. Clin Infect Dis (1995) 1.28
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Exploration of the microbial anatomy of normal human skin by using plasmid profiles of coagulase-negative staphylococci: search for the reservoir of resident skin flora. J Infect Dis (1989) 1.25
Coronavirus infections in working adults. Eight-year study with 229 E and OC 43. Am Rev Respir Dis (1972) 1.23
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Diagnosis of pneumococcal pneumonia by antigen detection in sputum. J Clin Microbiol (1978) 1.22
The effect of dilution during culture on detection of low concentrations of bacteria in blood. Pediatr Infect Dis (1984) 1.22
Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol (1982) 1.18
Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness. Am J Epidemiol (1969) 1.17
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis (1994) 1.15
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl (1984) 1.14
Inactivation of rhinovirus on human fingers by virucidal activity of glutaric acid. Antimicrob Agents Chemother (1984) 1.13
Relation between naturally acquired immunity and infectivity of two rhinoviruses in volunteers. J Infect Dis (1972) 1.13
Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis (1990) 1.12
Field trial of an inactivated Mycoplasma pneumoniae vaccine. I. Vaccine efficacy. J Infect Dis (1976) 1.12
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135. Proc Soc Exp Biol Med (1982) 1.09
Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother (1976) 1.09
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J Pediatr (1984) 1.09
Acute urethritis in male college students. JAMA (1973) 1.08
Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis (2000) 1.07
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Gram-negative bacilli as nontransient flora on the hands of hospital personnel. J Clin Microbiol (1987) 1.06
Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus colds. J Allergy Clin Immunol (1992) 1.04
Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age. J Pediatr (1987) 1.03
Rhinovirus infections in an industrial population. 3. Number and prevalence of serotypes. Am J Epidemiol (1968) 1.02
Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest (1982) 1.02
Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis (1990) 1.02
Prolonged stationary-phase growth of T-strain mycoplasmas in broth culture. Infect Immun (1972) 1.00
Shedding and survival of herpes simplex virus from 'fever blisters'. Pediatrics (1982) 1.00
Transient bacteremia during dental manipulation in children. Pediatrics (1973) 1.00
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
Comparison of historical and serologic immunity to varicella-zoster virus in 373 hospital employees. Am J Infect Control (1987) 0.99
Evaluation of virucidal compounds for inactivation of rhinovirus on hands. Antimicrob Agents Chemother (1978) 0.99
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Bacteriuria in children with neurogenic bladder treated with intermittent catheterization: natural history. J Pediatr (1995) 0.99
Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am Rev Respir Dis (1983) 0.97
Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine. J Infect Dis (1977) 0.97
A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis (1990) 0.97
An ultrastructural study of HIV-infected human dendritic cells and monocytes/macrophages. APMIS (1993) 0.97
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis (1985) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
Ascariasis: a family disease. J Pediatr (1974) 0.95
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol (1996) 0.95
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Rhinovirus inactivation by aqueous iodine in vitro and on skin. Proc Soc Exp Biol Med (1980) 0.95
Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination. JAMA (1973) 0.94
Rhinovirus transmission: one if by air, two if by hand. Trans Am Clin Climatol Assoc (1978) 0.94
Rhinovirus transmission: one if by air, two if by hand. Am J Epidemiol (1978) 0.94
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94